小细胞肺癌的最新情况
1Division of Thoracic Medical Oncology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut.
Seminars in respiratory and critical care medicine
|August 7, 2025
概括
小细胞肺癌 (SCLC) 治疗正在迅速发展,有新的化疗免疫疗法选择. 尽管生存率有所改善,但大多数患者仍然面临疾病进展,这凸显了对更好的治疗方法的持续需求.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 医学瘤学 医学瘤学
背景情况:
- 小细胞肺癌 (SCLC) 是一种侵略性的神经内分泌瘤,预后不佳,治疗选择有限.
- 晚期SCLC,诊断在70%的患者中,历史上5年生存率低于5%.
- 治疗耐药性和早期转移是SCLC的标志,这有助于其具有挑战性的性质.
研究的目的:
- 审查目前对SCLC的护理标准.
- 突出最近在SCLC治疗方面的进展和有前途的临床试验.
- 讨论SCLC患者的治疗结果和生存率的改善.
主要方法:
- 审查最近的SCLC临床试验和治疗批准.
- 分析一线,二线和整合性治疗策略.
- 专注于免疫疗法和新药在SCLC治疗中的影响.
主要成果:
- 晚期SCLC的第一线治疗现在结合了化疗和免疫疗法.
- 化学辐射治疗后的巩固性免疫疗法显著改善了早期SCLC的存活率.
- 最近的试验显示,使用化疗免疫治疗的高级SCLC的3年生存率为16-17% .
结论:
- 由于新的批准和改善的生存率,SCLC治疗已经取得了重大进展.
- 尽管取得了进展,但在一线治疗后疾病的快速进展仍然是一个挑战.
- 进一步的研究对于解决SCLC管理中未得到满足的需求至关重要.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.7K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
